JONES KENNETH T enters ZYNERBA PHARMACEUTICALS, INC. with 79.03K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 79.03K | Direct |
| Total | 79.03K | 79.03K direct |
Stock Option (right to buy)
DirectUnderlying shares
24K
Shares owned
N/A
Exercise price
11.71
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
22.50K
Shares owned
N/A
Exercise price
5.05
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
20K
Shares owned
N/A
Exercise price
3.65
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
20K
Shares owned
N/A
Exercise price
3.58
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
21.25K
Shares owned
N/A
Exercise price
2.41
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
35K
Shares owned
N/A
Exercise price
20.02
Expiration
—
Exercise window
—
Underlying
142.75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 11.71 | — | — | 24K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 5.05 | — | — | 22.50K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 3.65 | — | — | 20K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 3.58 | — | — | 20K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 2.41 | — | — | 21.25K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 20.02 | — | — | 35K | N/A |
| Total | 142.75K | 0.00 | ||||